News & Articles

New Rubella VLPs promise a reliable source of reagents for consistency in immunoassay development and manufacturing

Watch this on-demand webinar to learn how solutions from Sartorius are designed to increase the throughput of nanobody screening and discovery

ChLIA-based tests for detection of antibodies against Borrelia and Epstein-Barr virus now available on EUROIMMUN RA Analyzer 10 System

Discover a range of new technologies and applications for biopharmaceutical development in this special editorial feature

Find all the latest developments in antibody engineering and June’s top content from our drug discovery community

From rare pathogens to pandemic prevention, explore the latest techniques and technologies that are shaping today’s diagnosis and treatment of infectious diseases

This novel antibody labeling immunoassay for multiplex immune profiling aims to address one of the fastest growing, billion-dollar life science market sectors

Based on ESCAPE™ RNA sequencing technology, the latest proteogenomics assay is designed to characterize both RNA and protein expression levels across thousands of single CAR T cells

Avacta’s first Affimer clinical candidate is a potent PD-L1 antagonist under development for solid tumor indications as the basis of bispecific and combination therapies

High-throughput screening, antibody labeling, bispecific studies and more

SelectScience attended this year’s AAI IMMUNOLOGY conference to bring you the latest news and technology in the field

From lightning-fast labeling technology to real-time cytometry and high-throughput protein interaction analysis, find out what technologies are making the headlines in life sciences this month

As the global antibody market hits new heights, meet one scientist working to bridge the gap between biomarker discovery and antibody development with high-speed phage-display technology

Find all the latest developments and top content in our drug discovery community over the past month

Join this webinar to learn more about the new generation of therapeutic antibodies and find out how solutions from Sartorius can be used to accelerate their identification

Expedeon’s technology directly conjugates antibodies to enzymes, small molecules and fluorescent dyes

Real-time, live-cell imaging and analysis tools for effective antibody characterization

New isotype-specific secondary antibodies promise improved signal detection and specificity in imaging

A crosstalk-free 7-plex immunostaining method using widefield fluorescence microscopy shows promise for the detection of early-stage prostate cancer prediction

Partnership will develop conjugated FFPE IHC validated antibodies that are compatible with the GeoMx Digital Spatial Profiler